Abstract Reflux of bile acid into the esophagus induces esophagitis, inflammation-stimulated hyperplasia, metaplasia such as Barrett's esophagus (BE), and esophageal adenocarcinoma (EAC). Caudal-type homeobox 2 (Cdx2) via nuclear factor (NF)-jB induced by bile acid is an important factor in the development of BE and EAC. In colorectal cancer, experimental data suggest a chemopreventive effect of ursodeoxycholic acid (UDCA). We hypothesized that UDCA may protect against the esophageal inflammation-metaplasia-carcinoma sequence by decreasing the overall proportion of the toxic bile acids. Wistar male rats that underwent a duodenoesophageal reflux procedure were divided into two groups. One group was given commercial chow (control group), and the other was given experimental chow containing UDCA (UDCA group). The animals were killed at 40 weeks after surgery, and their bile and esophagus were examined. In the UDCA group, the esophagitis was milder and the incidence of BE was significantly lower (p \ 0.05) than in the control group, and EAC was not observed (p \ 0.05). In analysis of the compartment of bile acid, UDCA was markedly increased in the UDCA group compared with the control group (32.7 ± 11.4 vs. 0.82 ± 0.33 mmol/L, p \ 0.05) and cholic acid was decreased (32.7 ± 4.05 vs. 60.9 ± 8.26 mmol/L, p \ 0.05). Expression intensity of Cdx2 and NF-jB was greater in the control group than in the UDCA group (p \ 0.05). UDCA may be a chemopreventive agent against EAC by varying the bile acid composition.
Introduction
The incidence of esophageal adenocarcinoma (EAC) has recently been increasing, and its prognosis is extremely poor [1, 2] . Barrett's esophagus (BE) is assumed to be the result of chronic esophageal reflux and is a precursor lesion of EAC. The progress of gastroesophageal reflux disease (GERD) to EAC is thought to be involved in the inflammation-metaplasia-carcinoma sequence [3, 4] . Clinical studies have emphasized the role of chronic duodenogastroesophageal reflux in the development of BE [5] [6] [7] [8] . Several researchers have shown that not only gastric, but also duodenal reflux plays an important role in the pathogenesis of BE and EAC. Reflux of duodenal contents, including bile, is believed to contribute to the development and progression of BE and EAC [9] [10] [11] .
Caudal-type homeobox 2 (Cdx2) is a member of the caudal-related homeobox gene family. Some previous studies have shown that Cdx2 is one of the most important mediators in the process of BE development [12] [13] [14] [15] . Hydrophobic bile acid, such as deoxycholic acid (DCA), chenodeoxycholic acid (CDCA), and cholic acid (CA), activate Cdx2 via nuclear factor (NF)-jB activation in esophageal keratinocytes [12] . Cdx2 participates in the generation of EAC by regulating some intestine-specific tumor suppressors, such as guanylyl cyclase C [16, 17] .
Ursodeoxycholic acid (UDCA) is the most hydrophilic bile acid. UDCA has been used as a medical treatment for gallstone dissolution and commonly used for cholestatic liver diseases [18] . In contrast to hydrophobic acids that have cytotoxicity, UDCA is reported to have cytoprotective effects. It has become evident that UDCA is capable of exerting direct protective effects at the cellular and molecular level, including membrane stabilization, enhancement of defenses against oxidative stress, and inhibition of apoptosis induced by several agents [18, 19] . Bile acid hydrophobicity is an important determinant of the toxicity and protection of bile acids. Regarding the magnitude of hydrophobicity of bile acids, the order is UDCA \ CA \ CDCA \ DCA [20] . In a rodent colonic cancer model, UDCA has a preventive effect on carcinogenesis by decreasing the proportion of the cytotoxic bile acids [21, 22] . Moreover, clinical application of UDCA has been attempted for the prevention of colonic adenoma [23] .
We examined the chemopreventive effect of UDCA on inflammation-induced esophageal carcinogenesis using our established rat duodenoesophageal reflux (DER) model, which developed BE and EAC without administration of any carcinogens [24] .
Materials and methods

Animals and treatment procedures
Eight-week-old Wistar male rats weighing approximately 250 g were used. They were housed three to a cage and maintained under conditions of 22 ± 3°C room temperature and 55 ± 5 % humidity with a 12-h light-dark cycle. They were fed a standard solid chow, CRF-1 (Charles River Laboratories, Kanagawa, Japan) and tap water. After 24-h fasting, rat surgical models for the esophageal inflammation-metaplasia-carcinoma sequence induced by DER were employed under isoflurane inhalation anesthesia. Total gastrectomy was performed through an upper middle incision. The duodenal stump was closed with sutures, and the esophageal stump was anastomosed to the jejunum *4 cm distal to the Treitz ligament in an end-toside fashion. Intestinal anastomosis was carried out with interrupted full-thickness stitches using 8-0 atraumatic braided silk sutures. This procedure allowed the duodenal contents to flow back directly into the esophagus. The rats had free access to both water and food beginning 24 h after surgery. The animals were randomly divided into two groups: the control group (n = 14) was given commercial chow (CRF-1); the UDCA group (n = 10) was given experimental chow premixed with UDCA (0.4 %, 480 mg/ kg/day). The dosage of UDCA was based on a previous colonic tumor suppression study with exogenous carcinogens of rats [21, 22] . UDCA was obtained from Mitsubishi Tanabe Pharma Corporation (Osaka, Japan).
Pathological evaluation
The rats underwent laparotomy under isoflurane inhalation 40 weeks after surgery. After inspection of the intraperitoneal cavity, bile was collected from the common bile duct using a 24 G needle. After the animals were killed by deep anesthesia using pentobarbital sodium, the entire esophagus and jejunum of each rat (including anastomosis) were resected. After fixation in a 10 % formalin solution for 24 h, the esophagus was cut at 3-mm intervals along its length and embedded in paraffin. Five-micrometer sections of each block were prepared for histological evaluation using hematoxylin and eosin staining.
Definition of pathological findings
The pathological changes due to DER were defined as follows: regenerative thickening (RT), epithelial thickening to more than double the normal thickness, together with acanthosis, abnormal extension of papillae toward the mucosal surface, and parakeratosis; basal-cell hyperplasia (BCH), basal layer in the squamous epithelium thickened and occupying[15 % of the epithelium layer; erosion, lack of epithelium with cellular infiltration; BE, esophageal squamous epithelium replaced with columnar-lined epithelium comprising absorptive cells with brush borders and goblet cells; adenocarcinoma, epithelial growth with atypical cells and structure and invasion of the submucosal layer.
Immunohistochemistry
Localization of Cdx2 protein was determined by immunohistochemical staining using specific antibodies. The EnVision System (Dako, Glostrup, Denmark) was used with autoclave acceleration. Deparaffinized 5-lm sections of a formalin-fixed, paraffin-embedded block were immersed in absolute methanol containing 0.3 % hydrogen peroxidase and then covered with normal goat serum (1:30). Sections were incubated overnight at 4°C with primary antibody to rat Cdx2 protein (diluted 1:100) (Transduction Laboratory, Lexington, KY, USA). The sections were treated with labeled polymer (Dako) for 2 h. Immersing the sections in 3, 3-diaminobenzidine developed the reaction products. The slides were counterstained lightly with hematoxylin. Expression of NF-jB was also evaluated by immunohistochemical staining. Monoclonal mouse anti-rat NF-jB p-65 antigen (Dako) was used as the primary antibody with same immunohistochemical staining method as above. To evaluate the expression intensity of Cdx2 and NF-jB, labeled cells were counted per 1,000 epithelial cells in the esophageal epithelium up to 5 mm to the oral side of the anastomosis. The cells which nucleus was strongly stained were determined as IHC positive.
Bile acid analysis
Bile was collected from seven rats in each group. The bile was immediately frozen and stored at -70°C until analysis. Combining high-performance liquid chromatography (HPLC) and the immobilized enzyme in the presence of oxidized nicotinamide adenine dinucleotide (NAD) was used for bile acid analysis (SRL Corporation, Tokyo, Japan). The separation of individual bile acids was attained on a microcolumn using 0.3 % ammonium carbonate solution mixed with acetonitrile. 3a-Hydroxysteroid dehydrogenase was used as the immobilized enzyme. Reduced NAD generated from oxidized NAD and bile acids in the presence of 3a-hydroxysteroid dehydrogenase was determined on a fluorescence spectrometer. As the result, individual bile acids which were separated by HPLC were determined.
Statistical analysis
Fisher's exact test was used for statistical analysis of the incidence of pathological findings. Cdx2 expression and NF-jB expression were presented as the mean ± SD. Comparisons between groups were made using the MannWhitney U test. Differences were considered as significant when the p value was \0.05.
Results
Histopathological findings
In the control group, the distal portion of the esophagus was macroscopically thickened and irregular. In some parts of the rough epithelia, small nodular elevations were observed (Fig. 1a) . Severe squamous esophagitis, such as erosion, RT, and BCH, of the esophageal epithelia was observed in distal portions of the esophagus (Fig. 2a) . BE and EAC developed in the circumference of severe esophagitis (Figs. 3, 4) . In the control group, the incidence of BE and EAC was 71 and 64 %, respectively. In the UDCA group, the distal portions of the esophagus were relatively smooth and thickening was mild (Fig. 1b) . Squamous esophagitis was mild compared with the control group (Fig. 2b) . RT, BCH, and erosion were observed, but the degree was mild. The incidence of BE in the UDCA group was lower than in the control group (p \ 0.05). Moreover, no EAC was observed in the UDCA group (p \ 0.05) ( Table 1) .
Analysis of bile acid concentration and compartmentalization
The concentrations of UDCA, CA, and the others in the control group were 0.82 ± 0.33, 60.9 ± 8.26, and 4.10 ± 1.84 mmol/L, respectively. The concentrations of UDCA, CA, and the others in the UDCA group were 32.7 ± 11.4, 8.23 ± 4.05, and 6.65 ± 1.98 mmol/L, respectively. In the UDCA group, the level of UDCA was significantly increased (p \ 0.05) and CA was decreased (p \ 0.05) compared with the control group (Fig. 5) .
In the control group, the UDCA compartment accounted for 1.2 % (0.8-1.9 %) and CA for 92.3 % (87.0-96.9 %). In the UDCA group, the UDCA and CA compartments were 67.8 % (61.4-80.5 %) and 17.6 % (7.9-18.7 %), respectively. The proportion of each bile acid compartment is summarized in Fig. 6 . The proportion of UDCA, less toxic bile acid, was markedly increased, while the proportion of cytotoxic bile acids was significantly decreased in the UDCA group.
Immunohistochemistry of Cdx2 and NF-jB
Strong immunoreactivities for Cdx2 and NF-jB were demonstrated in epithelial cells of BE, EAC, and Fig. 1 Macroscopic appearance of the esophagus in rats autopsied at 40 weeks after surgery. In the control group, the distal esophagus was dilated and thickened, and the epithelium was uneven and had small nodules. In contrast, the esophagus of rats in the UDCA group had a smooth mucosal surface and showed no thickening squamous epithelium in the lower esophagus of the control group (Figs. 7c, 8c) . The immunoreactivities were weak in the UDCA group compared with the control group (Figs. 7b, 8b ). In the epithelium of the negative controls (normal rats), immunoreactivity for Cdx2 or NF-jB was hardly observed (Figs. 7a, 8a) .
Expression intensity of both Cdx2 and NF-jB in the squamous epithelium of the lower esophagus was greater in the control group compared with the UDCA group (p \ 0.05) (Figs. 9, 10) .
Discussion
The present study demonstrated that reflux of duodenal contents induces esophagitis and subsequently causes BE and EAC in rats. In this process, NF-jB and Cdx2 were upregulated in the esophageal epithelium. UDCA suppressed this inflammatory process and prevented the generation of BE and EAC. Analysis of bile acid revealed that the concentration of CA, which showed cytotoxicity, was reduced and the concentration of UDCA, which is less toxic, was increased. Esophageal carcinogenesis was suppressed by varying the bile acid fraction with the administration of UDCA.
It is assumed that chronic inflammation is associated with carcinogenesis in various types of cancer, and it plays an important role in esophageal carcinogenesis. It is widely accepted that bile acids, which are important constituents of duodenal fluid, are associated with the development of BE and EAC [12, 16, 25, 26] . Chronic reflux of bile acid into the esophagus induces severe esophagitis and activates cell proliferation. BE develops in such a cellular environment and leads to the generation of EAC [3, 25] . Nehra et al. [9] have reported that concentration of bile acids in the esophageal refluxate correlates with the degree of esophageal mucosal injury in patients with GERD. We have reported that BE and EAC develop from chronic esophagitis by using rodent DER models without exogenous carcinogens [24, 27] . Reflux of bile causes severe chronic (B) (A) Fig. 2 Microscopic findings in the distal esophagus. In the control group, severe squamous esophagitis was observed. In contrast, the degree of squamous esophagitis was milder in the UDCA group (white arrows indicate the anastomotic line, original magnification, 940) Fig. 3 Barrett's esophagus (BE) in the lower esophagus observed in the control group Ursodeoxycholic acid (UDCA) is used clinically for inflammatory diseases such as primary biliary cirrhosis, primary sclerosing cholangitis, and ulcerative colitis [3] . In the bile composition of healthy adults, the percentage of the cytotoxic hydrophobic bile acids (DCA, CA, and CDCA) is highest, and the hydrophilic acid (UDCA) occupies \5 %. By ingestion of UDCA, the ratio of UDCA increases up to 60 %, and conversely, hydrophobic bile acid decreases [28] . In recent years, the anticancer effect of UDCA against colon cancer in a rodent model has been demonstrated by a decrease in the overall proportion of the hydrophobic bile acids [21, 22] . In the present study, administration of UDCA reduced cytotoxic bile acids. As a result, inflammation of the esophageal epithelium was suppressed and generation of EAC was inhibited.
Recently, Cdx2 was reported to be expressed in the columnar epithelium and it is one of the key mediators in the generation of BE [12] [13] [14] [15] . In normal esophageal mucosa, Cdx2 is hardly visible. However, Cdx2 is seen in the columnar and esophageal epithelia in patients with esophagitis [15, 29] . Kazumori et al. [12] proved that chronic reflux of bile acids causes generation of BE though the expression of Cdx2 in a rat model. Burnet et al. [30] reported that DCA increases the carcinogenic potential through upregulation of Cdx2.
Both DCA and CA activate expression of Cdx2 via NFjB in esophageal keratinocytes [14] . NF-jB is an antiapoptotic, proinflammatory transcription factor. Activation of NF-jB has been linked to many types of cancer [31] . NFjB-binding sites are responsible for bile acid, and NF-jB activation promotes Cdx2 [12] . There are some evidences that activation of NF-jB causes progression of BE [26, 32] . Cdx2 expression through NF-jB activation by exposure to cytotoxic bile acid plays an important role in the development of BE. In contrast, the cytoprotective effects of UDCA by inhibiting activation of NF-jB have been reported by some researchers. The DNA damage induced by the activation of NF-jB is reduced by UDCA [33] , and UDCA suppresses activation of NF-jB through modulation of glucocorticoid receptor [34] . Decreased concentration of cytotoxic bile acid may alleviate expression of NF-jB and Cdx2.
In this study, UDCA prevented the development of BE and EAC, and changed the bile acid composition from hydrophobic to hydrophilic predominance, suggesting that inhibition of NF-jB/Cdx2 activation suppresses the inflammation-metaplasia-carcinoma sequence. UDCA may be a chemopreventive agent against EAC arising from esophageal reflux disease.
